Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion, |
RCV001775248 | SCV002011961 | likely pathogenic | Merosin deficient congenital muscular dystrophy | 2021-10-02 | criteria provided, single submitter | clinical testing | Inframe deletion located in a nonrepeat region: predicted to change the length of the protein and disrupt normal protein function (PM4). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant was observed in trans with a pathogenic variant (NM_000426.3: c.2049_2050del) as compound heterozygous (3billion dataset, PM3). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. |